Sie suchten nach: teoriskai (Litauisch - Englisch)

teoriskai xeomin poveik gali silpninti:
theoretically, the effect of xeomin may be reduced by:

teoriskai, vartojant nonafact, gali atsirasti antikni pries peli baltym.
in theory, therefore, the use of nonafact could generate antibodies to mouse protein.

teoriskai perdozavus gali labai sustiprti mao-a ir mao-b slopinimas.
theoretically, overdose can cause significant inhibition of both mao-a and mao-b.

-po gimdymo teoriskai tractocile gali sumazinti gimdos gebjim susitraukti.dl to gali
-after your baby has been delivered, tractocile may theoretically reduce the ability of the

teoriskai esant sustiprintai sveikai su kitais medicininiais produktais turi bti laikomasi atsargumo priemoni.
for reasons of theoretical considerations, enhanced interactions with other medicinal products must be expected as a precaution.

teoriskai aptivus, vartojamas su maza ritonaviro doze, gali padidinti itrakonazolio ar ketokonazolio koncentracij.
based on theoretical considerations aptivus, co-administered with low dose ritonavir, is expected to increase itraconazole or ketoconazole concentrations.

-azoto oksidu -kadangi abu vaistiniai preparatai slopina trombocit funkcij, teoriskai j derinys
-nitric oxide: since both medicinal products inhibit platelet function, their combination may in

palmitato, kuris yra esteris, kai visiskai hidrolizintas teoriskai atitinka ne daugiau kaip 5, 9 g sacharozs.
which is an ester, theoretically corresponds to maximally 5.9 grams of sucrose when fully hydrolyzed.

kadangi tolkaponas siterpia katecholamin metabolizm, teoriskai galimos sveikos su kitais vaistais, kurie veikia katecholamin koncentracijas.
since tolcapone interferes with the metabolism of catecholamines, interactions with other drugs affecting catecholamine levels are theoretically possible.

somatropino poveikis skydliauks hormon kiekiui gali bti kliniskai svarbus pacientams su centrine subklinikine hipotireoze, kuriems teoriskai gali issivystyti hipotireoz.
the effects of somatropin on thyroid hormone levels may be of clinical relevance in patients with central subclinical hypothyroidism in whom hypothyroidism theoretically may develop.

be to, kartu vartojant cyp3a4 induktorius ­ rifampicin, fenitoin, deksametazon arba fenobarbital, teoriskai gali sumazti beksaroteno koncentracija plazmoje.
furthermore, co-administration with cyp3a4 inducers such as rifampicin, phenytoin, dexamethasone or phenobarbital may theoretically cause a reduction in plasma bexarotene concentrations.

ferment indukcijos ir slopinimo duomenys rodo, kad teoriskai nra galimos metabolins tarpusavio sveikos reakcijos tarp kliniskai svarbi nos vartojamo flutikazono furoato dozi ir citochromo p450 metabolizuojam kit jungini.
the enzyme induction and inhibition data suggest that there is no theoretical basis for anticipating metabolic interactions between fluticasone furoate and the cytochrome p450 mediated metabolism of other compounds at clinically relevant intranasal doses.

teoriskai botulino neurotoksino poveikis gali bti sustiprintas vartojant aminoglikozid grups antibiotikus arba kitus vaistinius preparatus, kurie veikia impulso perdavim nervo-raumens jungtyje, pvz., tubokurarino tipo miorelaksantai.
theoretically, the effect of botulinum neurotoxin may be potentiated by aminoglycoside antibiotics or other medicinal products that interfere with neuromuscular transmission e. g. tubocurarine-type muscle relaxants.

p-gp substratas in vitro tyrimas rodo, kad zonisamidas yra silpnas p-gp (mdr1) su 267 µmol/l ic50 inhibitorius ir teoriskai zonisamidas gali veikti vaist, kurie yra p-gp substratai, farmakokinetik.
p-gp substrate an in vitro study shows that zonisamide is a weak inhibitor of p-gp (mdr1) with an ic50 of 267 µmol/l and there is the theoretical potential for zonisamide to affect the pharmacokinetics of drugs which are p-gp substrates.